Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea

PURPOSE: Epidermal growth factor receptor (EGFR) exon 20 insertion mutations account for approximately 4% of all EGFR mutations. Given the rarity of this mutation, its clinical outcomes are not fully established. MATERIALS AND METHODS: Between 2009 and 2017, non-small cell lung cancer (NSCLC) patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Byeon, Seonggyu, Kim, Youjin, Lim, Sung Won, Cho, Jang Ho, Park, Sehoon, Lee, Jiyun, Sun, Jong-Mu, Choi, Yoon-La, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473281/
https://www.ncbi.nlm.nih.gov/pubmed/30049203
http://dx.doi.org/10.4143/crt.2018.151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473281/
https://www.ncbi.nlm.nih.gov/pubmed/30049203
http://dx.doi.org/10.4143/crt.2018.151

Ejemplares similares